393 related articles for article (PubMed ID: 21305118)
1. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
Brewer GJ
Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
[TBL] [Abstract][Full Text] [Related]
2. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
3. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
4. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
5. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Brewer GJ
Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
[TBL] [Abstract][Full Text] [Related]
6. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Brewer GJ; Merajver SD
Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
8. The risks of free copper in the body and the development of useful anticopper drugs.
Brewer GJ
Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):727-32. PubMed ID: 18827576
[TBL] [Abstract][Full Text] [Related]
9. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
10. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
Wang XP; Yang RM; Ren MS; Sun BM
Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
[TBL] [Abstract][Full Text] [Related]
12. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
Brewer GJ
Nutrition; 1995; 11(1 Suppl):114-6. PubMed ID: 7749256
[TBL] [Abstract][Full Text] [Related]
13. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
[TBL] [Abstract][Full Text] [Related]
14. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease.
Esmaeli B; Burnstine MA; Martonyi CL; Sugar A; Johnson V; Brewer GJ
Cornea; 1996 Nov; 15(6):582-8. PubMed ID: 8899270
[TBL] [Abstract][Full Text] [Related]
15. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
17. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
[TBL] [Abstract][Full Text] [Related]
18. Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease.
Brewer GJ
Exp Biol Med (Maywood); 2001 Jul; 226(7):665-73. PubMed ID: 11444102
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]